133 related articles for article (PubMed ID: 10546705)
21. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
[TBL] [Abstract][Full Text] [Related]
22. Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women.
Sadate-Ngatchou P; Carter JJ; Hawes SE; Feng Q; Lasof T; Stern JE; Fu TC; Galloway DA; Koutsky LA; Winer RL
Sex Transm Dis; 2016 Mar; 43(3):192-8. PubMed ID: 26859807
[TBL] [Abstract][Full Text] [Related]
23. Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients.
Slavinsky J; Kissinger P; Burger L; Boley A; DiCarlo RP; Hagensee ME
Int J STD AIDS; 2001 Aug; 12(8):516-23. PubMed ID: 11487392
[TBL] [Abstract][Full Text] [Related]
24. The association between pregnancy and human papilloma virus prevalence.
Smith EM; Johnson SR; Jiang D; Zaleski S; Lynch CF; Brundage S; Anderson RD; Turek LP
Cancer Detect Prev; 1991; 15(5):397-402. PubMed ID: 1661203
[TBL] [Abstract][Full Text] [Related]
25. Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia.
Bedoya AM; Gaviria AM; Baena A; Borrero M; Duarte DF; Combita AL; Castaño J; Grisales H; Sánchez GI
Int J Gynecol Cancer; 2012 Feb; 22(2):303-10. PubMed ID: 22228426
[TBL] [Abstract][Full Text] [Related]
26. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.
Luostarinen T; af Geijersstam V; Bjørge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller JT; Thoresen S; Youngman LD; Dillner J; Lehtinen M
Int J Cancer; 1999 Mar; 80(6):818-22. PubMed ID: 10074912
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of human papillomavirus infection in women in Busan, South Korea.
Shin HR; Lee DH; Herrero R; Smith JS; Vaccarella S; Hong SH; Jung KY; Kim HH; Park UD; Cha HS; Park S; Touzé A; Muñoz N; Snijders PJ; Meijer CJ; Coursaget P; Franceschi S
Int J Cancer; 2003 Jan; 103(3):413-21. PubMed ID: 12471626
[TBL] [Abstract][Full Text] [Related]
28. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
Vaccarella S; Franceschi S; Herrero R; Muñoz N; Snijders PJ; Clifford GM; Smith JS; Lazcano-Ponce E; Sukvirach S; Shin HR; de Sanjosé S; Molano M; Matos E; Ferreccio C; Anh PT; Thomas JO; Meijer CJ;
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):326-33. PubMed ID: 16492924
[TBL] [Abstract][Full Text] [Related]
29. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women.
Svare EI; Kjaer SK; Nonnenmacher B; Worm AM; Moi H; Christensen RB; van den Brule AJ; Walboomers JM; Meijer CJ; Hubbert NL; Lowy DR; Schiller JT
J Infect Dis; 1997 Oct; 176(4):876-83. PubMed ID: 9333144
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States).
Hisada M; van den Berg BJ; Strickler HD; Christianson RE; Wright WE; Waters DJ; Rabkin CS
Cancer Causes Control; 2001 May; 12(4):335-41. PubMed ID: 11456229
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
Viscidi RP; Snyder B; Cu-Uvin S; Hogan JW; Clayman B; Klein RS; Sobel J; Shah KV
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):283-8. PubMed ID: 15668510
[TBL] [Abstract][Full Text] [Related]
32. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors.
Burk RD; Kelly P; Feldman J; Bromberg J; Vermund SH; DeHovitz JA; Landesman SH
Sex Transm Dis; 1996; 23(4):333-41. PubMed ID: 8836027
[TBL] [Abstract][Full Text] [Related]
33. Latent human papillomavirus infection in pregnant women at term: a case-control study.
Tenti P; Zappatore R; Migliora P; Spinillo A; Maccarini U; De Benedittis M; Vesentini N; Marchitelli G; Silini E; Carnevali L
J Infect Dis; 1997 Jul; 176(1):277-80. PubMed ID: 9207382
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.
Hagensee ME; Kiviat N; Critchlow CW; Hawes SE; Kuypers J; Holte S; Galloway DA
J Infect Dis; 1997 Sep; 176(3):625-31. PubMed ID: 9291307
[TBL] [Abstract][Full Text] [Related]
35. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand.
Sukvirach S; Smith JS; Tunsakul S; Muñoz N; Kesararat V; Opasatian O; Chichareon S; Kaenploy V; Ashley R; Meijer CJ; Snijders PJ; Coursaget P; Franceschi S; Herrero R
J Infect Dis; 2003 Apr; 187(8):1246-56. PubMed ID: 12696004
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
[TBL] [Abstract][Full Text] [Related]
37. [Risk factors and frequency of occurrence of HPV DNA of high oncogenic types in paraepidermal epithelium cells of the uterine cervix, in the trophoblast, and in the peripheral blood of pregnant patients].
Tarka A; Szczepańska M; Raczyńska D; Pruski D; Kedzia W; Opala T
Ginekol Pol; 2008 Dec; 79(12):871-6. PubMed ID: 19175046
[TBL] [Abstract][Full Text] [Related]
38. Risk factors associated with cervical human papillomavirus infections: a case-control study.
Kataja V; Syrjänen S; Yliskoski M; Hippelïnen M; Väyrynen M; Saarikoski S; Mäntyjärvi R; Jokela V; Salonen JT; Syrjänen K
Am J Epidemiol; 1993 Nov; 138(9):735-45. PubMed ID: 8237988
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy.
Syrjänen S; Waterboer T; Sarkola M; Michael K; Rintala M; Syrjänen K; Grenman S; Pawlita M
J Gen Virol; 2009 Jun; 90(Pt 6):1515-1526. PubMed ID: 19264653
[TBL] [Abstract][Full Text] [Related]
40. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
Nonnenmacher B; Kruger Kjaer S; Svare EI; Scott JD; Hubbert NL; van den Brule AJ; Kirnbauer R; Walboomers JM; Lowy DR; Schiller JT
Int J Cancer; 1996 Dec; 68(6):704-9. PubMed ID: 8980170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
